Deutsche Bank Ag\ Alnylam Pharmaceuticals, Inc. Transaction History

Deutsche Bank Ag\

$248 Billion
Q4 2024

A detailed history of Deutsche Bank Ag\ transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 556,579 shares of ALNY stock, worth $132 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

556,579

Previous 539,271 3.21%

Holding current value

$132 Million

Previous $148 Million 11.71%

% of portfolio

0.05%

Previous 0.06%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$232.27 - $300.43 $4.02 Million - $5.2 Million	17,308 Added 3.21%	556,579 $131 Million
Q3 2024 Nov 13, 2024	BUY	$233.81 - $287.01 $11.7 Million - $14.4 Million	50,153 Added 10.25%	539,271 $148 Million
Q2 2024 Aug 14, 2024	SELL	$143.31 - $247.0 $2.57 Million - $4.44 Million	-17,959 Reduced 3.54%	489,118 $119 Million
Q1 2024 May 15, 2024	BUY	$146.51 - $198.2 $6.56 Million - $8.87 Million	44,758 Added 9.68%	507,077 $75.8 Million
Q4 2023 Feb 14, 2024	SELL	$151.41 - $196.57 $81,307 - $105,558	-537 Reduced 0.12%	462,319 $88.5 Million
Q3 2023 Nov 09, 2023	SELL	$170.77 - $211.65 $4.1 Million - $5.08 Million	-24,020 Reduced 4.93%	462,856 $82 Million
Q2 2023 Aug 14, 2023	BUY	$185.01 - $212.05 $5.05 Million - $5.79 Million	27,310 Added 5.94%	486,876 $92.5 Million
Q1 2023 May 15, 2023	SELL	$182.66 - $235.53 $1 Million - $1.29 Million	-5,487 Reduced 1.18%	459,566 $92.1 Million
Q4 2022 Feb 13, 2023	BUY	$185.53 - $241.31 $39.2 Million - $51 Million	211,369 Added 83.32%	465,053 $111 Million
Q3 2022 Nov 14, 2022	BUY	$138.54 - $232.0 $891,781 - $1.49 Million	6,437 Added 2.6%	253,684 $50.8 Million
Q2 2022 Aug 11, 2022	SELL	$120.42 - $169.29 $4.2 Million - $5.9 Million	-34,863 Reduced 12.36%	247,247 $36.1 Million
Q1 2022 May 13, 2022	BUY	$127.18 - $173.91 $949,017 - $1.3 Million	7,462 Added 2.72%	282,110 $46.1 Million
Q4 2021 Feb 11, 2022	SELL	$159.56 - $209.29 $1.2 Million - $1.57 Million	-7,514 Reduced 2.66%	274,648 $46.6 Million
Q3 2021 Nov 04, 2021	BUY	$169.75 - $207.73 $2.94 Million - $3.6 Million	17,319 Added 6.54%	282,162 $53.3 Million
Q2 2021 Aug 11, 2021	BUY	$128.63 - $176.89 $805,352 - $1.11 Million	6,261 Added 2.42%	264,843 $44.9 Million
Q1 2021 May 13, 2021	SELL	$126.83 - $175.69 $4.4 Million - $6.09 Million	-34,685 Reduced 11.83%	258,582 $36.5 Million
Q4 2020 Feb 16, 2021	BUY	$122.97 - $147.0 $708,430 - $846,867	5,761 Added 2.0%	293,267 $38.1 Million
Q3 2020 Nov 12, 2020	BUY	$121.19 - $165.49 $171,605 - $234,333	1,416 Added 0.49%	287,506 $41.9 Million
Q2 2020 Aug 13, 2020	SELL	$104.21 - $156.44 $682,888 - $1.03 Million	-6,553 Reduced 2.24%	286,090 $42.4 Million
Q1 2020 May 14, 2020	BUY	$93.12 - $133.99 $1.06 Million - $1.53 Million	11,423 Added 4.06%	292,643 $31.9 Million
Q4 2019 Feb 14, 2020	SELL	$74.51 - $124.23 $27.9 Million - $46.5 Million	-374,410 Reduced 57.11%	281,220 $32.4 Million
Q3 2019 Nov 14, 2019	SELL	$70.9 - $87.82 $7.13 Million - $8.83 Million	-100,511 Reduced 13.29%	655,630 $52.7 Million
Q2 2019 Aug 14, 2019	BUY	$65.86 - $92.79 $19.7 Million - $27.8 Million	299,860 Added 65.72%	756,141 $54.9 Million
Q1 2019 May 15, 2019	BUY	$72.76 - $93.45 $18.6 Million - $23.9 Million	256,013 Added 127.84%	456,281 $42.6 Million
Q4 2018 Feb 14, 2019	SELL	$62.67 - $88.33 $6.54 Million - $9.22 Million	-104,328 Reduced 34.25%	200,268 $14.6 Million
Q3 2018 Dec 21, 2021	BUY	$87.52 - $122.67 $5.81 Million - $8.15 Million	66,427 Added 27.89%	304,596 $26.7 Million
Q3 2018 Nov 14, 2018	SELL	$87.52 - $122.67 $26.9 Million - $37.7 Million	-307,427 Reduced 56.35%	238,169 $20.8 Million
Q2 2018 Apr 21, 2020	BUY	$88.31 - $107.8 $6.44 Million - $7.86 Million	72,899 Added 15.42%	545,596 $53.7 Million
Q2 2018 Aug 14, 2018	BUY	$88.31 - $107.8 $2.3 Million - $2.81 Million	26,037 Added 5.83%	472,697 $46.6 Million
Q1 2018 Oct 18, 2019	BUY	$115.92 - $148.54 $6.71 Million - $8.6 Million	57,917 Added 14.9%	446,660 $53.2 Million
Q1 2018 May 15, 2018	BUY	$115.92 - $148.54 $20.6 Million - $26.4 Million	177,626 Added 84.14%	388,743 $46.3 Million
Q4 2017 Feb 14, 2018	BUY	$114.49 - $139.98 $4.31 Million - $5.27 Million	37,667 Added 21.72%	211,117 $26.8 Million
Q3 2017 Nov 14, 2017	BUY	$72.53 - $118.27 $12.6 Million - $20.5 Million	173,450	173,450 $20.4 Million

Others Institutions Holding ALNY

# of Institutions

667

Shares Held

112M

Call Options Held

839K

Put Options Held

771K

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $29.2B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account